Benjamin Oakes from Scribe Therapeutics shares how exciting advancements in CRISPR-based gene and epigenetic editing therapies impact the future of cardiovascular and cardiometabolic disease management. Summary Benjamin Oakes highlights the transformative potential of CRISPR technology, Read More